ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,993.62
      0.17%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. GeoVax Labs Inc (GOVX)

      7. GeoVax Labs Inc (GOVX) News

      GOVX

      GeoVax Labs (GOVX)

      GeoVax Labs Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GOVX
      DateTimeSourceHeadlineSymbolCompany
      04/04/202412:30PMGlobeNewswire Inc.GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineNASDAQ:GOVXGeoVax Labs Inc
      03/28/20249:00AMGlobeNewswire Inc.GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
      03/12/20249:00AMGlobeNewswire Inc.GeoVax to Present at the 36th Annual Roth ConferenceNASDAQ:GOVXGeoVax Labs Inc
      03/11/20244:13PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:GOVXGeoVax Labs Inc
      03/11/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
      03/11/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
      03/11/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
      03/11/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
      03/06/20249:00AMGlobeNewswire Inc.GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing SystemNASDAQ:GOVXGeoVax Labs Inc
      03/01/20244:08PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
      02/29/20244:05PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GOVXGeoVax Labs Inc
      02/29/20244:00PMGlobeNewswire Inc.GeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:GOVXGeoVax Labs Inc
      02/22/20244:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOVXGeoVax Labs Inc
      02/22/20249:00AMGlobeNewswire Inc.GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024NASDAQ:GOVXGeoVax Labs Inc
      02/19/20249:00AMGlobeNewswire Inc.GeoVax to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:GOVXGeoVax Labs Inc
      02/16/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
      02/14/20243:38PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GOVXGeoVax Labs Inc
      02/13/20249:00AMGlobeNewswire Inc.GeoVax Announces Multiple Patent Issuances and AllowancesNASDAQ:GOVXGeoVax Labs Inc
      02/07/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOVXGeoVax Labs Inc
      02/06/20249:00AMGlobeNewswire Inc.GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterNASDAQ:GOVXGeoVax Labs Inc
      01/31/20241:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
      01/29/20249:00AMGlobeNewswire Inc.GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementNASDAQ:GOVXGeoVax Labs Inc
      01/16/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
      01/12/20244:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXGeoVax Labs Inc
      01/12/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
      01/08/20249:00AMGlobeNewswire Inc.GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyNASDAQ:GOVXGeoVax Labs Inc
      01/04/20249:00AMGlobeNewswire Inc.GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer PatientsNASDAQ:GOVXGeoVax Labs Inc
      01/03/20249:00AMGlobeNewswire Inc.GeoVax Announces Issuance of Malaria Vaccine PatentNASDAQ:GOVXGeoVax Labs Inc
      01/02/20244:10PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
      12/27/20239:00AMGlobeNewswire Inc.GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024NASDAQ:GOVXGeoVax Labs Inc
       Showing the most relevant articles for your search:NASDAQ:GOVX